Lauren Martz
Head of product development coverage at BioCentury, specializing in clinical development and regulatory strategy for oncology and targeted therapies.
Best podcasts with Lauren Martz
Ranked by the Snipd community
9 snips
Feb 17, 2026 • 26min
Ep. 350 - Oral SERD Spotlight. Plus: Setbacks at FDA
Lauren Martz, product development lead covering oncology and targeted therapies, breaks down why oral SERDs are a catalyst-rich approach for ER+ HER2- breast cancer. Steve Usdin, Washington regulatory analyst, reviews recent FDA setbacks including a Moderna refusal to file and a CRL to Disc Medicine and calls for accountability at CBER. Short, focused takes on trial positioning, competitive mechanisms, and regulatory fallout.
